Tag: advanced therapy medicinal products contract development and manufacturing organization (cdmo) industry

  • Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2024: Size, Drivers, And Top Segments

    Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2024: Size, Drivers, And Top Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market from 2024 to 2033?
    The advanced therapy medicinal product contract development and manufacturing organization (CDMO) market has expanded rapidly in recent years. It is expected to grow from $4.55 billion in 2023 to $5.30 billion in 2024, at a CAGR of 16.7%. The growth can be linked to the rising number of ATMP clinical trials, increased researcher awareness of the benefits of advanced therapies, the availability of several ATMP CDMOs, ongoing efforts to develop novel therapies for various diseases, and supportive government initiatives.

    The advanced therapy medicinal product CDMO market is set to expand to $9.85 billion by 2028 at a CAGR of 16.8%. This growth is linked to increased investments from CDMOs and rising pharmaceutical R&D spending. Key trends include advancements in biomanufacturing facilities and the incorporation of technologies such as CRISPR.

    Claim Your Free Sample of the Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp

    What Key Factors Are Fueling the Growth of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
    An uptick in clinical trials is expected to accelerate the growth of the advanced therapy medicinal products CDMO market. Clinical trials evaluate the safety and efficacy of medical interventions and are increasing to meet the rising demand for innovative treatments. The demand for CDMO services is growing as advanced therapy products require specialized manufacturing expertise. Clinical trial data helps optimize manufacturing processes, ensuring scalability and quality. For example, the Association of the British Pharmaceutical Industry reported a 4.3% increase in clinical trials initiated in the UK, from 394 in 2021 to 411 in 2022. Thus, the increase in clinical trials is driving the advanced therapy medicinal products CDMO market.

    What Are the Major Segments of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
    1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
    2) By Phase: Phase I, Phase II, Phase III, Phase IV
    3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology

    What New Trends Are Transforming the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
    In the advanced therapy medicinal products CDMO market, companies are focusing on advanced cell therapy manufacturing services to address challenges in the field. For example, in January 2024, Pluristem Therapeutics launched PluriCDMO, utilizing a patented bioreactor system for 3D cell multiplication, facilitating scalable production of various cell types while ensuring quality consistency.

    Order Now for Fast Delivery of Your Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report!
    https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-contract-development-and-manufacturing-organization-cdmo-global-market-report

    Which Regions Are Driving Growth in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
    North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Include

    1. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Executive Summary
    2. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Segments
    3. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size And Template Market Growth Rate
    4.  Key Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trends
    5. Major Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market
    26. Top Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Companies
    27. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Opportunities And Strategies
    28. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report

    Advanced Ceramics Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/advanced-ceramics-global-market-report

    Advanced Biofuels Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/advanced-biofuels-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • “Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2024: Size, Drivers, And Top Segments

    “Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2024: Size, Drivers, And Top Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market from 2024 to 2033?

    The advanced therapy medicinal product contract development and manufacturing organization (CDMO) market has expanded rapidly in recent years. It is expected to grow from $4.55 billion in 2023 to $5.30 billion in 2024, at a CAGR of 16.7%. The growth can be linked to the rising number of ATMP clinical trials, increased researcher awareness of the benefits of advanced therapies, the availability of several ATMP CDMOs, ongoing efforts to develop novel therapies for various diseases, and supportive government initiatives.

    The advanced therapy medicinal product CDMO market is set to expand to $9.85 billion by 2028 at a CAGR of 16.8%. This growth is linked to increased investments from CDMOs and rising pharmaceutical R&D spending. Key trends include advancements in biomanufacturing facilities and the incorporation of technologies such as CRISPR.

    Claim Your Free Sample of the Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp

    What Key Factors Are Fueling the Growth of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?

    An uptick in clinical trials is expected to accelerate the growth of the advanced therapy medicinal products CDMO market. Clinical trials evaluate the safety and efficacy of medical interventions and are increasing to meet the rising demand for innovative treatments. The demand for CDMO services is growing as advanced therapy products require specialized manufacturing expertise. Clinical trial data helps optimize manufacturing processes, ensuring scalability and quality. For example, the Association of the British Pharmaceutical Industry reported a 4.3% increase in clinical trials initiated in the UK, from 394 in 2021 to 411 in 2022. Thus, the increase in clinical trials is driving the advanced therapy medicinal products CDMO market.

    What Are the Major Segments of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?

    1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered

    2) By Phase: Phase I, Phase II, Phase III, Phase IV

    3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology

    What New Trends Are Transforming the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?

    In the advanced therapy medicinal products CDMO market, companies are focusing on advanced cell therapy manufacturing services to address challenges in the field. For example, in January 2024, Pluristem Therapeutics launched PluriCDMO, utilizing a patented bioreactor system for 3D cell multiplication, facilitating scalable production of various cell types while ensuring quality consistency.

    Order Now for Fast Delivery of Your Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report!

    https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-contract-development-and-manufacturing-organization-cdmo-global-market-report

    Which Regions Are Driving Growth in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?

    North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Include

    1. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Executive Summary

    2. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Segments

    3. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size And Template Market Growth Rate

    4. Key Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trends

    5. Major Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

    26. Top Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Companies

    27. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Opportunities And Strategies

    28. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report

    Advanced Ceramics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/advanced-ceramics-global-market-report

    Advanced Biofuels Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/advanced-biofuels-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2024 – Top Market Trends And Opportunities

    Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2024 – Top Market Trends And Opportunities

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Rapid Market Growth and Projections
    The advanced therapy medicinal product (ATMP) contract development and manufacturing organization (CDMO) market has experienced significant growth, expanding from $4.55 billion in 2023 to an estimated $5.30 billion in 2024. This growth represents a robust compound annual growth rate (CAGR) of 16.7%. The market’s future looks even brighter, with projections indicating it will reach $9.85 billion by 2028 at a CAGR of 16.8%.

    • Current Market Size: $4.55 billion in 2023
    • Projected Growth: $5.30 billion in 2024
    • Forecasted Market Size: $9.85 billion by 2028

    Drivers of Growth
    Several factors are driving the expansion of the ATMP CDMO market:

    • Increased Clinical Trials: The surge in clinical trials for ATMPs is a significant driver. Rising clinical trial numbers are critical as they test and validate innovative therapies.
    • Rising Awareness: Growing recognition of the benefits of advanced therapies among researchers has bolstered demand.
    • Supportive Initiatives: Government initiatives aimed at advancing medical research and therapy development contribute to market growth.

    Read More On The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-contract-development-and-manufacturing-organization-cdmo-global-market-report

    Clinical Trials: A Key Growth Factor
    The increase in clinical trials is crucial for the ATMP CDMO market. Clinical trials are essential for evaluating new treatments and therapies, creating a higher demand for CDMO services. These trials ensure the scalability and quality of manufacturing processes.

    • Rising Trials: For instance, in the UK, industry clinical trials increased by 4.3% from 2021 to 2022.
    • Impact on CDMOs: More trials translate to higher demand for specialized manufacturing expertise and infrastructure.

    Innovation in Cell Therapy Manufacturing
    Advancements in cell therapy manufacturing are transforming the ATMP CDMO landscape. Companies are developing new services and technologies to address manufacturing challenges and accelerate development.

    • Pluristem Therapeutics: Launched PluriCDMO, offering advanced cell therapy manufacturing with a patented 3D bioreactor system.
    • Goal: Provide scalable, cost-effective cell therapies with consistent quality.

    Expansions and Acquisitions
    Strategic acquisitions are shaping the ATMP CDMO market, allowing companies to expand their capabilities and service offerings.

    • Recipharm AB: Acquired Vibalogics in February 2022 to enhance its biologic capabilities and enter new modalities, including viral vector production.

    Market Segmentation
    The ATMP CDMO market is segmented by product, phase, and indication:

    • By Product: Gene Therapy, Cell Therapy, Tissue Engineered
    • By Phase: Phase I, Phase II, Phase III, Phase IV
    • By Indication: Oncology, Cardiology, CNS & Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology & Inflammation, Ophthalmology, Hematology

    Regional Insights

    • North America: Led the market in 2023 due to a strong presence of major CDMOs and high R&D investments.
    • Asia-Pacific: Expected to be the fastest-growing region, driven by increasing investments and emerging market players.

    Conclusion
    The advanced therapy medicinal product CDMO market is on an upward trajectory, driven by increasing clinical trials, technological advancements, and strategic expansions. As the industry continues to evolve, the demand for specialized CDMO services will likely surge, presenting ample opportunities for growth and innovation.

    Request for A Sample Of The Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=15719&type=smp